Semaglutide
Synthetic peptide studied in clinical and preclinical models for body composition modulation and glycemic regulation
Last updated: March 1, 2026
- Compound
- Semaglutide
- Class
- Body Composition peptide
- Summary
- Synthetic peptide studied in clinical and preclinical models for body composition modulation, glycemic regulation, appetite & satiety modulation.
- Mechanism
- Systemic Metabolic & Cardiovascular Effects
- Research Status
- Approved
- Routes Studied
- Subcutaneous injection via auto-injector pen
- Evidence Level
- Clinically validated · Approved therapeutic
What Should You Know About Semaglutide?
- What is Semaglutide?
- Semaglutide is a synthetic peptide studied in clinical and preclinical models for body composition modulation and glycemic regulation.
- Is Semaglutide clinically proven?
- Semaglutide is an approved therapeutic with established clinical evidence.
- What has Semaglutide been studied for?
- Semaglutide has been studied in clinical and preclinical settings of body composition modulation, glycemic regulation, appetite & satiety modulation and has received regulatory approval in at least one jurisdiction.
- Is Semaglutide approved?
- Semaglutide is an approved therapeutic in at least one jurisdiction. Regulatory status varies by country. Consult a local specialist for guidance.
What Is Semaglutide?
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist consisting of a 31-amino acid peptide backbone with targeted structural modifications that dramatically extend its pharmacokinetic profile compared to native GLP-1. Originally developed through systematic peptide engineering, semaglutide incorporates a C-18 fatty diacid chain attached via a linker to the lysine residue at position 26, enabling reversible binding to serum albumin. This albumin-binding modification, combined with an amino acid substitution at...
Evidence Summary
Semaglutide is an approved therapeutic with established clinical evidence and regulatory approval in at least one jurisdiction.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Body Composition Modulation | Limited |
| Glycemic Regulation | Limited |
| Appetite & Satiety Modulation | Limited |
| Cardiovascular Risk Marker Improvement | Limited |
| Human clinical evidence | Established |
| Safety data | Established |
Editorial Position
Semaglutide is an approved therapeutic with established clinical evidence. As with any pharmaceutical compound, individual suitability should be discussed with a specialist.
Regulatory Status Snapshot
- Approved as a therapeutic drug in at least one jurisdiction
- Safety and efficacy established through regulatory review processes
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for Semaglutide is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has Semaglutide Been Studied For?
Research areas where Semaglutide has been investigated in published studies
-
Body Composition Modulation Semaglutide has been studied in clinical and preclinical studies of body composition modulation.
-
Glycemic Regulation Semaglutide has been studied in clinical and preclinical studies of glycemic regulation.
-
Appetite & Satiety Modulation Semaglutide has been studied in clinical and preclinical studies of appetite & satiety modulation.
-
Cardiovascular Risk Marker Improvement Semaglutide has been studied in clinical and preclinical studies of cardiovascular risk marker improvement.
How Does Semaglutide Work?
These mechanisms have been established through clinical and preclinical research.
- 01 GLP-1 Receptor Binding
- 02 Hypothalamic Appetite Regulation
- 03 Glucose-Dependent Insulin Potentiation
- 04 Gastric Motility Modulation
Not sure if Semaglutide is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Semaglutide.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate Semaglutide
How Is Semaglutide Administered?
Semaglutide is available via Subcutaneous injection via auto-injector pen. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of Semaglutide?
What Conditions Has Semaglutide Been Linked To?
Have Questions About Semaglutide?
Yes. Semaglutide requires thorough medical evaluation before and during use. Pre-treatment screening includes thyroid function assessment, metabolic panel, evaluation of pancreatitis and gallbladder disease history, and assessment for contraindications including medullary thyroid carcinoma risk.
Published studies on Semaglutide can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
Semaglutide is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.
Ready to discuss Semaglutide with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026